Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease.
Alzheimer disease and associated disorders.
Times cited: 30
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).
Alzheimer's & dementia : the journal of the Alzheimer's Association.
Times cited: 34
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Human molecular genetics.
Times cited: 149
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.
Journal of the American Academy of Dermatology.
Times cited: 829